Unique Ingredient Identifier 23OV73Q5G9 is listed as a ingredient substance
RN | 55589-62-3 |
EC | 259-715-3 |
NCIT | C76512 |
RXCUI | 1310545 |
MF | C4H4NO4S.K |
INCHI KEY | WBZFUFAFFUEMEI-UHFFFAOYSA-M |
SMILES | [K+].CC1=CC([O-])=NS(=O)(=O)O1 |
UNII 23OV73Q5G9 ACESULFAME POTASSIUM is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
BUCCAL | GUM | 2.35 MG |
BUCCAL | GUM, CHEWING | 7.35 MG |
DENTAL | SOLUTION | 0.12 % |
ORAL | FILM, SOLUBLE | 1.6 MG |
ORAL | LOZENGE | 6 mg |
ORAL | POWDER, FOR ORAL SOLUTION | 117 MG |
ORAL | POWDER, FOR SUSPENSION | 45 MG/5ML |
ORAL | SOLUTION | 10 MG/1ML |
ORAL | SOLUTION, LIQUID | 4.5 MG/1ML |
ORAL | SUSPENSION | 10 MG/5ML |
ORAL | SUSPENSION, LIQUID | 7.5 MG/5ML |
ORAL | TABLET | 8 MG |
ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 3.75 MG |
ORAL | TABLET, CHEWABLE | 6 MG |
ORAL | TABLET, DISPERSIBLE | 1 MG |
ORAL | TABLET, EFFERVESCENT, FOR SOLUTION | 4 MG |
ORAL | TABLET, FILM COATED | 8.19 MG |
ORAL | TABLET, FOR SUSPENSION | 1.8 MG |
ORAL | TABLET, ORALLY DISINTEGRATING | 8 MG |
ORAL | TABLET, UNCOATED, LOZENGE | 1.5 MG |
ORAL | TROCHE | 1.7 MG |
SUBLINGUAL | FILM | 3 mg |
SUBLINGUAL | TABLET | 4.4 MG |